Company

CSL

Type: public
Ticker: CSL · ASX
Market value: $80B

CSL is public, listed as CSL on ASX, in Healthcare and pharmaceuticals.

What it sells: plasma therapies, flu vaccines.

In the language of this map it serves 2 solutions — Specialist medicine and Childhood vaccination — which between them relieve 3 human frictions.

Its neighbourhood

Everything this entry connects to directly. Click any point to follow it.

Sells

Specialist medicineLate career
Childhood vaccinationInfancy

Human frictions it ultimately relieves

Reached through the solutions above, never directly.

Conditions accumulate and specialists multiplyLate career
The body costs more each yearRetirement
Keep a fragile newborn aliveInfancy

Trends favouring it

Longevity biotech and cell/gene therapyReal but not yet at scale. The effects described are expected rather than observed.
Pandemic preparedness and biosecurityDirection genuinely disputed. Reasonable people expect opposite outcomes.